
A therapy that arms the immune system to find and destroy tumor cells has shown early promise against a rare and aggressive childhood cancer. Experts called the findings “promising.” But they cautioned that much larger studies are needed to see whether and how the treatment can fit into battling the cancer, called neuroblastoma. Neuroblastoma begins… read on > read on >